[血小板抑制剂治疗中的控制临床方面]
[Clinical aspects of control in therapy with platelet inhibitors].
作者信息
Bokarev I N, Ovcinnikova L V, Aleksandrova N A, Kabaeva E V, Marcukova E V, Kun I S, Olbinskaja L I
出版信息
Folia Haematol Int Mag Klin Morphol Blutforsch. 1979;106(5-6):776-82.
PMID:94869
Abstract
46 patients with ischaemic heart disease were treated with Micristin (20-40 mg/kg) or a combination of Micristin and Propranolol (80-120 mg/die). The values of bleeding time, the platelet factor 4 in lysate of thrombocytes or in plasma of patients as well as the soluble fibrin monomer complexes were investigated. They showed no obvious correlation to the clinical findings.
摘要
46例缺血性心脏病患者接受了米克里斯汀（20 - 40毫克/千克）治疗，或米克里斯汀与普萘洛尔（80 - 120毫克/日）联合治疗。对出血时间、患者血小板裂解物或血浆中的血小板因子4以及可溶性纤维蛋白单体复合物的值进行了研究。它们与临床发现无明显相关性。
Zotero 插件